• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Generic drugs

Mergers MA spinoff arrows merging arrows
Pharma

Mallinckrodt, Endo become Keenova following generics spinoff

Some three months after merging, Mallinckrodt and Endo have successfully spun off their combined sterile injectables and generics businesses.
Fraiser Kansteiner Nov 11, 2025 9:54am
Coral Springs Florida

Lupin to lay out $250M for new Fla. manufacturing facility

Oct 9, 2025 9:02am
Surescripts settlement commentary

Gilead inks Biktarvy settlements with 3 generic drug makers

Oct 7, 2025 7:40am
FDA

FDA drafts new policies to boost US drug production

Oct 3, 2025 3:52pm
settlement

AbbVie settles lawsuit to ward off Rinvoq generics until 2037

Sep 11, 2025 1:36pm
Graphic of two hands shaking under a red and purple light

PE firm strikes €4.1B deal for Czech generics maker Zentiva: FT

Sep 11, 2025 10:25am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings